Physicochemical analysis and biological characterization of FKB327 as a biosimilar to adalimumab

Stefan Schreiber, Katsuhiko Yamamoto, Rafael Muniz, Takafumi Iwura

Open source

DOI: 10.1002/prp2.604
Published: 2020-06
Container: Pharmacology Research & Perspectives
Publisher: Wiley
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/prp2.604,
  title = {Physicochemical analysis and biological characterization of FKB327 as a biosimilar to adalimumab},
  author = {Stefan Schreiber and Katsuhiko Yamamoto and Rafael Muniz and Takafumi Iwura},
  year = {2020},
  journal = {Pharmacology Research \&amp; Perspectives},
  doi = {10.1002/prp2.604},
  url = {https://doi.org/10.1002/prp2.604}
}

RIS

TY  - JOUR
TI  - Physicochemical analysis and biological characterization of FKB327 as a biosimilar to adalimumab
AU  - Stefan Schreiber
AU  - Katsuhiko Yamamoto
AU  - Rafael Muniz
AU  - Takafumi Iwura
PY  - 2020
JO  - Pharmacology Research &amp; Perspectives
DO  - 10.1002/prp2.604
UR  - https://doi.org/10.1002/prp2.604
ER  -

APA

Schreiber, S., Yamamoto, K., Muniz, R., & Iwura, T. (2020). Physicochemical analysis and biological characterization of FKB327 as a biosimilar to adalimumab. Pharmacology Research & Perspectives. https://doi.org/10.1002/prp2.604

Source records

crossref · retrieved 2026-09-25T07:30:16.487Z